The greatest hot-weather drink you've probably never heard of

Delicious spicy food and hot summer weather are two of Turkey's greatest assets. But when these two ingredients combine, you're going to need something to keep temperatures from getting out of hand. Thankfully, Turkey has you covered on this front too, with a drink so refreshing, it's a mystery to some why everyone hasn't heard of it.
This is ayran, a deceptively simple mix of fresh yogurt, water and salt. After a sweltering or strenuous afternoon in the sun, slurping down a chilled glass of this tasty combination will leave your body gasping with appreciation.
It may not match everyone's taste, and will be off-limits to some dietary requirements, but the appeal of ayran — pronounced eye-ran — is undeniable. It's been drunk in the region where Europe meets Asia for centuries and today is sold in various forms across Turkey and several other countries.
And its refreshing properties get a big thumbs up from science.
'Consuming ayran is an important means of restoring mineral balance lost through perspiration in the summer, due to its natural mineral content and the presence of added salt,' Professor Barbaros Özer from Ankara University's Faculty of Agriculture, Department of Dairy Technology told CNN. He explained that the beverage contains valuable minerals and protein.
That's not all. Another surprising benefit is the drink's effects on digestive and intestinal health. 'Ayran plays a crucial role in maintaining the balance of gastrointestinal health and the intestinal microbiota,' added Özer.
Turkic peoples are believed to have been producing ayran for at least a millennium — making it about 900 years older than Coca-Cola.
Thanks to Besim Atalay, a Turkish linguist who lived in the late 19th and early 20th centuries, ayran's roots have been traced back to the 11th century, gaining a mention in Mahmud al-Kashgari's Dīwān Lughāt al-Turk, the first-known dictionary of Turkic languages, written at the time.
It's safe to say that ayran is a product of necessity. Fermented food and drink like cheese, yogurt and ayran are perfect for long journeys. Turkic nomads prepared fermented dairy products to extend their usability, helping overcome the formidable climate of the steppes, the vast, treeless grasslands they called home.
While Turks migrated from Central Asia to Anatolia (the land that makes up most of modern day Turkey), ayran moved with them. Editor and gastronomy researcher Merin Sever told CNN that we know through historical travelogues that people in Anatolia prepared ayran. Their daily meals also included 'bread chopped into yogurt or bread added as a supplement to ayran.'
During their migration, Turks probably left traces of the drink, influencing other cultures.
Iran's doogh is similar to a type of ayran, called yayık ayran, in Turkey, a byproduct of buttermilk production. Central Asian Turkic people have chal and kumis. However, these two are made of fermented milk — camel milk and mare's milk, respectively.
While most ayran is made of yogurt, the commercial mass production of the drink includes a milk fermentation process. 'Industrial ayran is produced in two different ways: either by diluting yogurt to the targeted protein content, or by fermenting milk after it has been diluted to the target protein level,' explains Özer.
Today, ayran is not only a part of a thousand-year-old Turkish culinary tradition but also among the most commercialized drinks in modern Turkey. From shelves in large supermarkets to street food vendor barrels, it quenches thirst and accompanies meals across the country.
Even global fast-food brands like McDonald's and Burger King include ayran as an option in their meals in Turkey
At a kebab restaurant or a büfe — small food vendors that serve Turkish fast food such as döner sandwiches — when you order ayran, you may be asked: 'Do you want open ayran (açık ayran) or closed ayran (kapalı ayran)?'
To make sense of this, you need to be familiar with ayran culture. Closed ayran is packaged and mass-manufactured, while open ayran is freshly mixed to order in restaurants and vendors.
Most Turkish people prefer open ayran because… Well, it's somehow more delicious.
Anyone looking for a genuine traditional experience should look for places where ayran is served in copper cups, such as kebab shops called 'ocakbaşı,' where you can sit in front of the grills and watch your meal order prepared on metal skewers.
To watch meat cook slowly over sizzling embers — liquid fat dripping down, spreading an appetizing smell — and sipping ice-cold ayran from its copper cup is a true Turkish experience.
Or, following a night out in Istanbul's buzzing Taksim district, stopping at a food carts selling pilaf (rice dish) with several toppings — mostly chicken or chickpeas — in Taksim Square or on İstiklal Street and checking to see if they have a plastic barrel with a tap. Inside are liters of delicious homemade ayran.
In fact, pilaf and ayran are among the methods Turks use to combat hangovers.
While it's simple and straightforward to prepare ayran, there are many variations.
Susurluk ayran, local to the Susurluk district of Balıkesir, a city in northwestern Turkey, is usually prepared from a yogurt with a higher content of fat, which creates a foam on the drink's surface.
Yayık ayran is another widespread type that is a byproduct of butter making. Buttermilk replaces yogurt, which creates a highly frothy texture and a less tangy taste.
Turkey's eastern Malatya region is known for its spicy ayran, prepared with green or red hot chili peppers. It has a distinct taste that appeals to fans of sweet and sour, or sweet and salty foods.
There are likely hundreds of other recipes. For example, you can add a pinch of mint for extra refreshment, or even skip adding salt. Sometimes, sparkling mineral water is used instead of still for a crisper taste.
Many factors affect the taste of ayran besides extra ingredients like pepper, salt, or mint. Mostly, however, it comes down to the yogurt. 'Which milk was used to make the yogurt, how fatty was the yogurt, the yeast that was used to make it, and how it was used — industrial or traditional methods were used — all impact the taste of ayran,' Sever, the gastronomy researcher, explained.
Associate Professor Özge Samancı, head of the Gastronomy and Culinary Arts Department at Turkey's Özyeğin University, agrees: 'A good, fatty yogurt gives ayran its flavor.'
So, despite its widespread consumption in and around Turkey, why is ayran not popular worldwide?
Samancı says it's largely down to unfamiliarity.
'Turkish cuisine is generally not well-known abroad, and related products are unavailable in the market,' she told CNN. 'Turkish restaurants are few in number and limited. Secondly, the taste of classic ayran, without additions like mint etc., is strange to foreigners, who often do not like this sour taste.'
But which version of ayran should visitors to Turkey try to get the best experience? It's all a matter of personal taste — for instance Özer, the gastronomy professor, prefers industrial ayran because of its hygienic properties, while Samancı and Sever choose open ayran.
'If I pass through a region famous for its dairy products, I definitely try to taste the local, freshly made open ayran,' Sever said.
Samancı specifically enjoys Susurluk ayran, which she says pairs perfectly with a traditional Susurluk melted cheese sandwich.
Whichever you choose, once you've enjoyed that refreshing ayran taste, you'll almost certainly be back for more.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Medscape

an hour ago

• Medscape

Novel GLP-1 Agonist Promotes Safe and Effective Weight Loss

Ecnoglutide, a novel glucagon-like peptide-1 (GLP-1) receptor agonist, was significantly more effective than placebo for inducing weight loss in adults with overweight or obesity, based on data from more than 600 individuals, results of the SLIMMER trial showed. In addition, ecnoglutide significantly improved other key cardiometabolic risk factors including waist circumference, blood pressure, lipid profile, A1c, fasting glucose, insulin level, and uric acid, while concurrently reducing liver fat content, said study author Linong Ji, MD, of Peking University People's Hospital, Beijing, China. "These benefits position ecnoglutide as a compelling therapeutic strategy for managing clinical obesity, especially in the context of metabolic dysfunction and associated steatotic liver disease (MASLD)," he noted. The results of the phase 3 randomized trial were presented here at the American Diabetes Association (ADA) 85th Scientific Sessions and simultaneously published in The Lancet Diabetes & Endocrinology . The new drug is distinct from other GLP-1 receptor agonists in its ability to selectively induce production of cyclic adenosine monophosphate (cAMP). Unlike unbiased GLP-1 therapies, ecnoglutide selectively activates cAMP signaling pathways while minimizing β-arrestin recruitment, which may explain its enhanced effectiveness for body weight reduction and sustained metabolic effects, Ji said in an interview. Weight Loss at All Doses The researchers randomized 664 overweight and obese Chinese adults to a weekly dose of 1.2 mg, 1.8 mg, or 2.4 mg of ecnoglutide or to placebo. The coprimary endpoints were percentage change in body weight and proportion of individuals with a reduction of 5% or more in body weight after 40 weeks. The study population included adults aged 18-75 years with overweight or obesity, defined as a BMI of 28 kg/m² or higher, or 24 kg/m² or higher with at least one weight-related comorbidity (prediabetes, hypertension, hyperlipidemia, MASLD, obstructive sleep apnea syndrome, or weight-bearing joint pain), but without type 1 or 2 diabetes. The mean age of participants was 34.2 years, and half were female. Individuals in the ecnoglutide group had an average body weight loss of 9.1%, 10.9%, and 13.2% from baseline at 40 weeks at doses of 1.2 mg, 1.8 mg, and 2.4 mg, respectively, which was significantly greater at all dose levels than placebo (0.1%) ( P < 0.0001 vs placebo for all doses). In addition, significantly more patients in the ecnoglutide groups lost at least 5% of their body weight at week 40 compared to the placebo group (77%, 84%, 87%, and 16% in the 1.2-mg, 1.8-mg, 2.4-mg, and placebo groups, respectively). A key secondary efficacy endpoint was the percentage of individuals who achieved a body weight loss of at least 5% after 48 weeks; 78% to 93% of participants across the ecnoglutide groups achieved this endpoint, with the greatest changes at the higher doses. Ten individuals across the ecnoglutide groups discontinued the medication because of adverse events, the most common of which were mild-to-moderate gastrointestinal events. Treatment-emergent adverse events occurred in 93% of participants in each of the ecnoglutide groups and in 84% of the placebo group. Clinical Takeaways and Next Steps "Ecnoglutide not only represents a viable competitor in the GLP-1 analog market but also stands out with its potential to address the nonresponse limitations in obesity treatment while providing holistic metabolic benefits," Ji told Medscape Medical News . At least 10% of weight-loss patients fail to achieve clinically significant weight loss of at least 5%, he explained. Possible reasons for the lack of success include genetic polymorphisms, metabolic heterogeneity, treatment compliance, or differential receptor sensitivity, he noted. "Providing alternative treatment options with a high response rate is crucial for individuals nonresponsive to existing therapies," he said. The trial results mark a milestone in obesity therapeutics and are a significant achievement in weight management. "After 48 weeks of treatment, ecnoglutide achieved a 15.4% weight reduction, with 92.8% of patients attaining clinically meaningful weight loss," he emphasized. "Considering the high potency of ecnoglutide" and the safety data, "it might serve as a viable option for individuals who do not achieve sufficient weight reduction with existing GLP-1 receptor agonists at their approved doses or need to achieve a better reduction in body weight," he added. "I am confident and optimistic that we'll see more personalized treatment regimens for obesity." Looking ahead, patients in the ecnoglutide 1.8-mg and 2.4-mg groups continued to have weight loss at week 48 without reaching a plateau, indicating that even greater weight loss might be possible with extended ecnoglutide treatment in studies of longer duration, Ji told Medscape Medical News . "To confer the added clinical advantage, a study comparing the clinical effects of a biased GLP-1 analog with those of a pharmacokinetically-matched but balanced GLP-1 analog would be needed," he said. In an accompanying editorial, Tricia M-M Tan, PhD, of Imperial College, London, UK, wrote: "The development of biased GLP-1 receptor agonists has been met with enthusiasm from the pharmaceutical industry, but does this design feature really confer any added clinical advantage?" She agreed with Ji that a comparative study of "a biased GLP-1 analog with those of a pharmacokinetically-matched but balanced GLP-1 analog" is needed. "Only then will the clinical role of this design feature be clear," she said. However, "the clinical results from ecnoglutide are likely to be generalizable to other populations," given that the effects of GLP-1 analogs are similar when tested in patients of various ethnicities, she said, adding this may increase the global availability of GLP-1 treatments. Refining Molecules to Enhance Efficacy, Reduce Side Effects Although current therapies represent potent, effective options for obesity-modifying treatment, they have limitations, with heterogeneity of responses in terms of potency and tolerability, said Andrew Kraftson, MD, a specialist in endocrinology and internal medicine at the University of Michigan, Ann Arbor, in an interview. "Ecnoglutide continues the trend to refine these molecules to enhance efficacy and reduce side effects," he said. "When these types of peptides interact with cells, they activate certain receptors and generate a signal cascade that promotes the desired effects. However, the less specific the 'message', the less potent the signal. Additionally, side effects can be a result of the less-controlled message," he noted. As with tirzepatide, ecnoglutide was developed to produce a "biased" signal with the intent to provide greater control of the signal/message to increase the odds of weight control and reduce the odds of side effects, he explained. Although the current study was not a head-to-head comparison with other incretin mimetics, the similarity in weight loss efficacy to tirzepatide, a dual GLP-1/glucagon insulinotropic peptide agonist (GIP), was interesting and supports the biasing effect of the molecular manipulation as an effective strategy to refine incretin therapy, Kraftson told Medscape Medical News . From a clinical standpoint, the trend towards refining weight management therapy will benefit patients by expanding their options, said Kraftson. "It may also help us address the observed heterogeneity in clinical response we see in our patients and bring us closer to personalized medicine," he said. The current study's limitations, as acknowledged by the researchers, include the relatively short time period, small sample size, and lack of head-to-head comparison, said Kraftson. Additionally, the study differs from clinical practice in its dose escalation, he said. In practice, "we are not trying to get patients to a certain dose, we are trying to find the lowest, most tolerable, and sufficiently effective dose to achieve health goals; therefore, we may determine that dose titration needs to happen more slowly and/or that a low(er) dose may be sufficiently effective," he told Medscape Medical News . "The adverse event data for common gastrointestinal issues could potentially be better in clinical practice if mitigation strategies are employed," he said. "I would like to see future studies that go beyond finding the relative efficacy of doses to reporting on effective strategies for patient-dose matching."

Bloomberg

3 hours ago

• Bloomberg

Chinese Biotech Showcases Challenger to Eli Lilly's Obesity Drug

An obesity drug from China helped patients lose a lot of weight in a late-stage clinical trial, making it a prospective new challenger to blockbusters from Novo Nordisk A/S and Eli Lilly & Co. Hangzhou Sciwind Biosciences Co. said its drug, ecnoglutide, led to more than 15% weight loss after 48 weeks when given at the highest dose. Although the trial did not compare ecnoglutide directly with existing medicines, the results were very similar to what Lilly's Zepbound showed in previous China studies, Sciwind Chief Executive Officer Hai Pan said in an interview.

Associated Press

7 hours ago

• Associated Press

The Istanbul Nose: A Closer Look at Rhinoplasty with Dr. Şaban Çelebi

06/21/2025, Istanbul ,Istanbul // KISS PR Brand Story PressWire // For anyone who has spent years feeling self-conscious about their nose, the thought of changing it is a powerful one. It's that feature right in the middle of your face, the one you can't hide. You've probably spent countless hours analyzing it in the mirror, wondering what it would be like to just… feel good about your profile. This journey of consideration often leads to a deep dive down the Instagram and Google rabbit hole, and that rabbit hole almost inevitably leads to one destination: Istanbul. The city is a global hub for aesthetic surgery, especially rhinoplasty. But with so many surgeons to choose from, the process can feel overwhelming. As you sift through countless before-and-after pictures, certain names start to stand out. One of those names that consistently pops up, often surrounded by praise for natural-looking results, is Dr. Şaban Çelebi. So, let's take a closer, honest look at what makes him a sought-after surgeon in such a competitive field. The Man Behind the Profile First things first, who is Dr. Şaban Çelebi? He's an ENT (Ear, Nose, and Throat) specialist. This is a pretty significant detail. It means his entire medical background is rooted in the complex anatomy of the nose. He understands not just how a nose should look, but how it needs to function. The goal isn't just a pretty nose, it's a nose that you can breathe through properly, and his specialization speaks volumes about that dual focus. Dr. Çelebi operates of his own clinic, a well-known and modern facility in Istanbul. This isn't a one-man shop but a professional medical institution, which adds a layer of comfort and security for international patients. His reputation is built on a foundation of experience and a clear, consistent aesthetic. The 'Signature' Nose: Artistry Meets Anatomy If you spend some time looking at Dr. Çelebi's results, a certain style begins to emerge. The noses he creates are elegant, refined, and beautifully sculpted. However, they don't look 'done.' He seems to have a real talent for creating a nose that harmonizes perfectly with the rest of the patient's facial features. It's not about stamping the same 'Barbie nose' on every face, but about crafting a unique result that looks like it's the nose the person should have been born with. He is known for creating delicate slopes and refined tips, but always with an eye toward maintaining the person's ethnic identity and overall facial balance. This artistic approach, combined with his deep medical understanding of nasal structure, is likely the key to his success. The Patient Journey: From Apprehension to the Big Reveal So, what does the journey actually look like for someone travelling to see him? It usually starts with an online consultation. You send your photos, explain your concerns and what you're hoping to achieve. This initial step helps manage expectations and gives you a feel for their communication style. If you decide to move forward, you'll typically book a package deal. This is one of the biggest draws of getting surgery in Turkey. These packages often include your stay in a comfortable hotel, a private driver for all your appointments, and, of course, the surgery itself. It takes a huge amount of stress out of the equation. The most crucial part of the process happens when you arrive: the in-person consultation with Dr. Çelebi. This is where you have a real conversation, where he listens to your goals and provides his professional opinion on what's realistically achievable. This is the moment to build trust and ensure you're both on the same page. The surgery itself takes a few hours under general anesthesia. The recovery period is key, and the clinic provides detailed instructions for post-operative care. The 'big reveal,' when the cast finally comes off, is an emotional moment for every rhinoplasty Turkey patient, marking the first glimpse of a new chapter. What Are People Actually Saying? A surgeon's website will always show their best work. That's why independent review sites, forums, and patient testimonials are so important. When you look up Dr. Çelebi, the feedback is overwhelmingly positive. Patients frequently praise his calm and reassuring bedside manner, his ability to truly listen, and his meticulous attention to detail. Many highlight how the result exceeded their expectations, finally giving them the confidence they'd been chasing for years. Of course, rhinoplasty Istanbul is a major, life-altering surgery. No surgeon is the right fit for everyone. It's essential to do your own research, to look at hundreds of photos (both good and bad healing examples), and to make sure the surgeon's aesthetic aligns with your own. The Financial Side Let's talk about the cost. Rhinoplasty with a top surgeon in the US or UK can easily run into five figures. In Turkey, the price is significantly more accessible. While costs vary, you are generally looking at a fraction of that price for a full package with Dr. Çelebi. It's not 'cheap,' because quality medical care is never cheap. But it is an incredible value when you consider the level of surgical talent and the all-inclusive service you receive. It's an investment in yourself and your confidence. Final Thoughts Choosing a surgeon for a rhinoplasty is one of the most important decisions you can make. It's a choice based on trust, artistry, and a shared vision. Dr. Şaban Çelebi has firmly established himself as a master of his craft, renowned for creating natural, functional, and life-changing results. He represents the best of what Istanbul's medical tourism scene has to offer: world-class skill at an attainable price. Original Source of the original story >> The Istanbul Nose: A Closer Look at Rhinoplasty with Dr. Şaban Çelebi